These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
323 related articles for article (PubMed ID: 22439649)
1. The relationship between drug clearance and body size: systematic review and meta-analysis of the literature published from 2000 to 2007. McLeay SC; Morrish GA; Kirkpatrick CM; Green B Clin Pharmacokinet; 2012 May; 51(5):319-30. PubMed ID: 22439649 [TBL] [Abstract][Full Text] [Related]
2. Encouraging the move towards predictive population models for the obese using propofol as a motivating example. McLeay SC; Morrish GA; Kirkpatrick CM; Green B Pharm Res; 2009 Jul; 26(7):1626-34. PubMed ID: 19337821 [TBL] [Abstract][Full Text] [Related]
3. Propofol clearance in morbidly obese children and adolescents: influence of age and body size. Diepstraten J; Chidambaran V; Sadhasivam S; Esslinger HR; Cox SL; Inge TH; Knibbe CA; Vinks AA Clin Pharmacokinet; 2012 Aug; 51(8):543-51. PubMed ID: 22690673 [TBL] [Abstract][Full Text] [Related]
4. Prediction of clearance and volume of distribution in the obese from normal weight subjects: an allometric approach. Mahmood I Clin Pharmacokinet; 2012 Aug; 51(8):527-42. PubMed ID: 22671778 [TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetics and pharmacodynamics of propofol in morbidly obese patients. van Kralingen S; Diepstraten J; Peeters MY; Deneer VH; van Ramshorst B; Wiezer RJ; van Dongen EP; Danhof M; Knibbe CA Clin Pharmacokinet; 2011 Nov; 50(11):739-50. PubMed ID: 21973271 [TBL] [Abstract][Full Text] [Related]
6. Accuracy of pharmacokinetic models for predicting plasma fentanyl concentrations in lean and obese surgical patients: derivation of dosing weight ("pharmacokinetic mass"). Shibutani K; Inchiosa MA; Sawada K; Bairamian M Anesthesiology; 2004 Sep; 101(3):603-13. PubMed ID: 15329584 [TBL] [Abstract][Full Text] [Related]
7. Body size indices to determine iodine mass with contrast-enhanced multi-detector computed tomography of the upper abdomen: does body surface area outperform total body weight or lean body weight? Kondo H; Kanematsu M; Goshima S; Watanabe H; Kawada H; Moriyama N; Bae KT Eur Radiol; 2013 Jul; 23(7):1855-61. PubMed ID: 23508277 [TBL] [Abstract][Full Text] [Related]
8. Towards a better prediction of peak concentration, volume of distribution and half-life after oral drug administration in man, using allometry. Sinha VK; Vaarties K; De Buck SS; Fenu LA; Nijsen M; Gilissen RA; Sanderson W; Van Uytsel K; Hoeben E; Van Peer A; Mackie CE; Smit JW Clin Pharmacokinet; 2011 May; 50(5):307-18. PubMed ID: 21456631 [TBL] [Abstract][Full Text] [Related]
9. Body weight-dependent pharmacokinetics of busulfan in paediatric haematopoietic stem cell transplantation patients: towards individualized dosing. Bartelink IH; Boelens JJ; Bredius RG; Egberts AC; Wang C; Bierings MB; Shaw PJ; Nath CE; Hempel G; Zwaveling J; Danhof M; Knibbe CA Clin Pharmacokinet; 2012 May; 51(5):331-45. PubMed ID: 22455797 [TBL] [Abstract][Full Text] [Related]
10. What is the best size descriptor to use for pharmacokinetic studies in the obese? Green B; Duffull SB Br J Clin Pharmacol; 2004 Aug; 58(2):119-33. PubMed ID: 15255794 [TBL] [Abstract][Full Text] [Related]
11. Prediction of drug clearance in children: impact of allometric exponents, body weight, and age. Mahmood I Ther Drug Monit; 2007 Jun; 29(3):271-8. PubMed ID: 17529882 [TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics of high-dose methotrexate in children with acute lymphoblastic leukaemia. Aumente D; Buelga DS; Lukas JC; Gomez P; Torres A; García MJ Clin Pharmacokinet; 2006; 45(12):1227-38. PubMed ID: 17112298 [TBL] [Abstract][Full Text] [Related]
13. Propofol Clearance in Morbidly Obese Children and Adolescents : Influence of Age and Body Size. Diepstraten J; Chidambaran V; Sadhasivam S; Esslinger HR; Cox SL; Inge TH; Knibbe CA; Vinks AA Clin Pharmacokinet; 2012 Aug; 51(8):543-551. PubMed ID: 28258392 [TBL] [Abstract][Full Text] [Related]
14. Pediatric Obesity: Pharmacokinetics and Implications for Drug Dosing. Kendrick JG; Carr RR; Ensom MH Clin Ther; 2015 Sep; 37(9):1897-923. PubMed ID: 26361823 [TBL] [Abstract][Full Text] [Related]
15. Lean body mass as a predictor of drug dosage. Implications for drug therapy. Morgan DJ; Bray KM Clin Pharmacokinet; 1994 Apr; 26(4):292-307. PubMed ID: 8013162 [TBL] [Abstract][Full Text] [Related]
16. Comparison of Dose Adjustment Strategies for Obesity in High-dose Cyclophosphamide Among Adult Hematopoietic Cell Transplantation Recipients: Pharmacokinetic Analysis. Takahashi T; Jaber MM; Al-Kofahi M; Weisdorf D; Brunstein C; Bachanova V; Brundage RC; Jacobson PA; Kirstein MN Transplant Cell Ther; 2022 Dec; 28(12):845.e1-845.e8. PubMed ID: 36167308 [TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetics of busulfan in children: increased evidence for body surface area and allometric body weight dosing of busulfan in children. Trame MN; Bergstrand M; Karlsson MO; Boos J; Hempel G Clin Cancer Res; 2011 Nov; 17(21):6867-77. PubMed ID: 21918171 [TBL] [Abstract][Full Text] [Related]
18. Predicting oral clearance in humans: how close can we get with allometry? Sinha VK; De Buck SS; Fenu LA; Smit JW; Nijsen M; Gilissen RA; Van Peer A; Lavrijsen K; Mackie CE Clin Pharmacokinet; 2008; 47(1):35-45. PubMed ID: 18076217 [TBL] [Abstract][Full Text] [Related]
19. A guide to rational dosing of monoclonal antibodies. Bai S; Jorga K; Xin Y; Jin D; Zheng Y; Damico-Beyer LA; Gupta M; Tang M; Allison DE; Lu D; Zhang Y; Joshi A; Dresser MJ Clin Pharmacokinet; 2012 Feb; 51(2):119-35. PubMed ID: 22257150 [TBL] [Abstract][Full Text] [Related]
20. Vancomycin dosing in children and young adults: back to the drawing board. Camaione L; Elliott K; Mitchell-Van Steele A; Lomaestro B; Pai MP Pharmacotherapy; 2013 Dec; 33(12):1278-87. PubMed ID: 24019205 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]